Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: Tamtam, Lakers_w, MiamiGent, desarcmo
Search This Board: 
Last Post: 5/19/2022 1:18:32 PM - Followers: 647 - Board type: Free - Posts Today: 0

INOVIO'S Impressive pipeline

Inovio's 86,851,493 shares of common stock outstanding as of December 31, 2020

Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
9:15 AM ET 1/23/20 | PR Newswire

PLYMOUTH MEETING, Pa., Jan. 23, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9 million to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV) that has killed numerous people and infected hundreds more in China to date. This initial CEPI funding will support Inovio's preclinical and clinical development through Phase 1 human testing of INO-4800, its new coronavirus vaccine matched to the outbreak strain. CEPI previously awarded Inovio a grant of up to $56 million for the development of vaccines against Lassa fever and Middle East Respiratory Syndrome (MERS), also caused by a coronavirus.

Inovio's participation in this developing effort is based on the ideal suitability of its DNA medicine platform to rapidly develop a vaccine against an emerging virus with pandemic potential, proven vaccine development capabilities and a strong track record of rapidly generating promising countermeasures against previous pandemic threats. Inovio was the first to advance its vaccine (INO-4700) against MERS-CoV, a related coronavirus, into evaluation in humans. Inovio is currently preparing to initiate a Phase 2 vaccine trial for INO-4700 in the Middle East where most MERS viral outbreaks have occurred.

In a recently published paper in Lancet Infectious Diseases, Inovio's Phase 1 study of its MERS-CoV vaccine demonstrated it was well tolerated and furthermore induced high levels of antibody responses in roughly 95% of subjects, while also generating broad-based T cell responses in nearly 90% of study participants. Durable antibody responses to INO-4700 were also maintained through 60 weeks following dosing.

Richard Hatchett, CEPI's CEO, said, "Given the rapid global spread of the 2019-nCoV virus the world needs to act quickly and in unity to tackle this disease. Our intention with this work is to leverage our work with Inovio on the MERS coronavirus and rapid response platform to speed up vaccine development."

Dr. J. Joseph Kim, Inovio's President & CEO said, "We're extremely honored to expand our partnership with CEPI to tackle this new threat to global public health. Our DNA medicine platform represents the best modern day approach to combatting emerging pandemics. We have already demonstrated positive clinical outcomes with our vaccine against MERS-CoV, another coronavirus. Importantly, following the Zika viral infection outbreak, Inovio and our partners developed a vaccine that went from bench to human testing in just seven months -- the fastest vaccine development on record in recent decades. We believe we can further improve upon this accelerated timeline to meet the current challenge of the emerging Chinese coronavirus 2019-nCoV."

DISCLAIMER The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.

Whatch out for fake comments by manipulators

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#39337  Sticky Note Information for new readers/investors which should do their Tamtam 11/09/21 01:10:04 PM
#14894  Sticky Note Inovio has no "vaccine". A vaccine implies something MiamiGent 01/28/20 07:18:32 PM
#40235   I don’t see monkey or smallpox in their gew59 05/19/22 01:18:32 PM
#40234   Guess that is why it is up so desarcmo 05/19/22 01:01:36 PM
#40233   They already have one. From 2010 gew59 05/19/22 10:45:18 AM
#40232   I hear INO can create a vaccine for desarcmo 05/19/22 10:43:03 AM
#40231   Way off? Sold in high twenties! If making surfnsk8 05/18/22 12:09:50 PM
#40229   INO Why is he getting continual stock options? MiamiGent 05/18/22 09:56:13 AM
#40228   To pay the tax’s on his options! Wow surfnsk8 05/18/22 09:42:58 AM
#40227   INO Inovio Insider David B. Weiner sold shares MiamiGent 05/18/22 09:05:58 AM
#40226   INO You edited my sentence, cutting off, "in MiamiGent 05/17/22 09:46:47 AM
#40225   INO "Hostile takeover" LOL MiamiGent 05/15/22 02:29:19 PM
#40224   INO Buy what? Inovio has nothing. MiamiGent 05/15/22 02:05:21 PM
#40223   INO What?? MiamiGent 05/15/22 01:59:22 PM
#40222   INO "It's All Over" MiamiGent 05/15/22 01:44:08 PM
#40221   Strong Candidate for Acquisition Opus X 05/15/22 08:44:15 AM
#40220   A fair assessment. Thanks for posting gew59. MiamiGent 05/14/22 08:37:13 PM
#40219   A good summary. ……. https://endpts.com/inovios-longtime-ceo-is-out-as-covid-vac gew59 05/14/22 07:53:25 AM
#40217   INO Well, we know Inovio's Mr. Everything, Dirty MiamiGent 05/13/22 06:37:17 PM
#40216   INO No US agency will be touching Inovio MiamiGent 05/13/22 11:06:59 AM
#40215   WHO and MPP announce agreement with NIH for doc2016 05/13/22 09:48:59 AM
#40214   Get out now?? Tamtam 05/12/22 06:21:07 AM
#40213   No it didn’t hit ten cents today. We’re Tamtam 05/12/22 06:11:00 AM
#40212   INO Get out now, in my opinion. MiamiGent 05/11/22 08:59:00 PM
#40211   INO Here's a typical warning from me, dated MiamiGent 05/11/22 08:48:03 PM
#40210   INO I have been consistently railing against INO MiamiGent 05/11/22 08:42:32 PM
#40209   INO Inovio hit .10 today (ten cents), when MiamiGent 05/11/22 08:05:15 PM
#40208   Inovio's longtime CEO is out as Covid vaccine Frenchy2016 05/11/22 03:45:44 PM
#40207   9:20a ET 5/11/2022 - MarketWatch Inovio Pharmaceuticals stock price gew59 05/11/22 09:42:48 AM
#40206   Well, that was an interesting conference call. gew59 05/10/22 05:25:38 PM
#40205   Thank MG for the reminder. Quarterly excuse call. …… https://ir.inovio.com/inve gew59 05/06/22 11:04:41 PM
#40204   INO Inovio hit .1650 today (sixteen and a MiamiGent 05/06/22 08:16:34 PM
#40203   Information for new readers/investors which should do their Tamtam 05/01/22 05:09:57 PM
#40202   False information Avtar Dhillon never was INO’s founder Tamtam 05/01/22 05:03:52 PM
#40201   Passed over technology. MiamiGent 05/01/22 03:52:53 PM
#40200   Inovio!-Wow!- https://www.linkedin.com/posts/jpeocbrnd_jpeocbrnd-cbrn-biotechnology-activity-6925813 smoke_em 04/29/22 11:14:24 PM
#40199   Denmark becomes the first country to halt its gew59 04/28/22 10:20:28 AM
#40198   DNA-Based Vaccines Opus X 04/28/22 09:11:53 AM
#40197   Fauci says U.S. is transitioning out of 'pandemic phase' …….. https://www.nbcn gew59 04/27/22 02:44:22 PM
#40196   INO It is very important for investors, especially MiamiGent 04/27/22 07:50:00 AM
#40195   NOWHERE in this article does it mention any smoking guns 04/27/22 12:11:19 AM
#40194   Sounds like Kim - raising funds, selling shares… gew59 04/26/22 08:58:46 PM
#40193   INO News story about Avtar Dhillon, MiamiGent 04/26/22 08:19:13 PM
#40192   INO, the company which claimed to be uniquely MiamiGent 04/26/22 07:57:09 PM
#40191   INOVIO to Report First Quarter 2022 Financial Results radly 04/26/22 03:06:52 PM
#40190   Lakers, everything / news as been very quite larryxxx10 04/25/22 02:29:29 PM
#40189   Any update on this? gew59 04/21/22 07:28:10 PM
#40188   Japan officially approves Novavax COVID-19 vaccine ………. https://www3.nhk.or.jp/n gew59 04/20/22 08:33:48 AM
#40187   INO My message to the SEC- "Delist this MiamiGent 04/18/22 03:29:09 PM
#40186   INO Broke under $3.00,. Now $2.98, LOD. MiamiGent 04/18/22 03:23:45 PM
#40185   INO Inovio is hit .1875 (eighteen & three MiamiGent 04/18/22 02:53:58 PM
#40178   False information Tamtam 04/17/22 06:45:35 PM
Consent Preferences